Genotype-phenotype correlations in recessive titinopathies
Autor: | Marco Savarese, Olivera Casar-Borota, Nuria Muelas, Claudio Bruno, Anna Sarkozy, Guja Astrea, Christoffer Ehrstedt, Marika Pane, Ricardo Rojas-García, Rita Barresi, Thierry Kuntzer, Jordi Díaz-Manera, Fortunato Lonardo, Bjarne Udd, Mridul Johari, Alessandro Malandrini, Juan J. Vílchez, Eugenio Mercuri, Francesco Muntoni, Sushan Luo, Giorgio Tasca, Ana Ferreiro, C. Julien, Mark M. Davis, Heidi Fodstad, Annalaura Torella, Salla Välipakka, Amets Sáenz, Vincenzo Nigro, Manu Jokela, Adolfo López de Munain, Emily C. Oates, Anna Vihola, Peter Hackman, Chiara Fiorillo, Isabel Illa, Filippo M. Santorelli, Talha Qureshi, H. Luque, Philippe Petiot, Chong Bo Zhao |
---|---|
Přispěvatelé: | University of Helsinki, Folkhälsan Research Center, Faculty of Medecine [Helsinki], University of Helsinki-University of Helsinki, Fimlab Laboratories [Tampere, Finland], School of Biotechnology and Biomolecular Sciences, University of New South Wales [Sydney] (UNSW), Translational and Clinical Research Institute, Newcastle University, IRCCS Istituto Giannina Gaslini [Genoa, Italy], Fondazione 'Policlinico Universitario A. Gemelli' [Rome], Tampere University Hospital, MRC Centre for Neuromuscular Diseases, University College of London [London] (UCL), Huashan Hospital [Shangai], CIBER de Enfermedades Raras (CIBERER), Uppsala University, Biodonostia Health Research Institute, Lausanne University Hospital, Service d'Explorations Fonctionnelles Respiratoires, Groupement Hospitalier Nord, Hôpital de la Croix-Rousse (Hospices Civiles de Lyon), Lyon, France, parent, Università degli studi della Campania 'Luigi Vanvitelli', IRCCS Fondazione Stella Maris [Pisa], Institut de Myologie, Centre National de la Recherche Scientifique (CNRS)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Association française contre les myopathies (AFM-Téléthon)-Sorbonne Université (SU), Unité de Biologie Fonctionnelle et Adaptative (BFA (UMR_8251 / U1133)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Paris (UP), Università degli Studi di Siena = University of Siena (UNISI), Uppsala University Hospital, QEII Medical Centre, Helsingin yliopisto = Helsingfors universitet = University of Helsinki, Helsingin yliopisto = Helsingfors universitet = University of Helsinki-Helsingin yliopisto = Helsingfors universitet = University of Helsinki, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università degli studi della Campania 'Luigi Vanvitelli' = University of the Study of Campania Luigi Vanvitelli, Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Association française contre les myopathies (AFM-Téléthon)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), Savarese, M., Vihola, A., Oates, E. C., Barresi, R., Fiorillo, C., Tasca, G., Jokela, M., Sarkozy, A., Luo, S., Diaz-Manera, J., Ehrstedt, C., Rojas-Garcia, R., Saenz, A., Muelas, N., Lonardo, F., Fodstad, H., Qureshi, T., Johari, M., Valipakka, S., Luque, H., Petiot, P., de Munain, A. L., Pane, M., Mercuri, E., Torella, A., Nigro, V., Astrea, G., Santorelli, F. M., Bruno, C., Kuntzer, T., Illa, I., Vilchez, J. J., Julien, C., Ferreiro, A., Malandrini, A., Zhao, C. -B., Casar-Borota, O., Davis, M., Muntoni, F., Hackman, P., Udd, B. |
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
[SDV]Life Sciences [q-bio]
VARIANT MYOPATHY 0302 clinical medicine Genotype congenital myopathy Medicine Missense mutation Connectin C-TERMINAL TITIN Child Genetics (clinical) Genetics 0303 health sciences arthrogryposi Genetic disorder High-Throughput Nucleotide Sequencing musculoskeletal system Hypotonia 3. Good health Phenotype Cohort Muscle Hypotonia medicine.symptom Cohort study EXPRESSION TTN Nonsense mutation LINE skeletal muscle disorders SEQUENCE arthrogryposis 03 medical and health sciences skeletal muscle disorder cardiomyopathy titin Humans TRUNCATING MUTATIONS Genetic Association Studies 030304 developmental biology TIBIAL MUSCULAR-DYSTROPHY business.industry medicine.disease Congenital myopathy GENE arthrogryposis cardiomyopathy congenital myopathy skeletal muscle disorders titin Mutation business 030217 neurology & neurosurgery |
Zdroj: | Genetics in Medicine Genetics in Medicine, Nature Publishing Group, 2020, 22 (12), pp.2029-2040. ⟨10.1038/s41436-020-0914-2⟩ Genetics in Medicine, 2020, 22 (12), pp.2029-2040. ⟨10.1038/s41436-020-0914-2⟩ GENETICS IN MEDICINE r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau instname r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe r-IIB SANT PAU: Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau Institut dInvestigació Biomèdica Sant Pau (IIB Sant Pau) |
ISSN: | 1098-3600 1530-0366 |
DOI: | 10.1038/s41436-020-0914-2⟩ |
Popis: | International audience; Purpose High throughput sequencing analysis has facilitated the rapid analysis of the entire titin (TTN) coding sequence. This has resulted in the identification of a growing number of recessive titinopathy patients. The aim of this study was to (1) characterize the causative genetic variants and clinical features of the largest cohort of recessive titinopathy patients reported to date and (2) to evaluate genotype-phenotype correlations in this cohort. Methods We analyzed clinical and genetic data in a cohort of patients with biallelic pathogenic or likely pathogenicTTNvariants. The cohort included both previously reported cases (100 patients from 81 unrelated families) and unreported cases (23 patients from 20 unrelated families). Results Overall, 132 causative variants were identified in cohort members. More than half of the cases had hypotonia at birth or muscle weakness and a delayed motor development within the first 12 months of life (congenital myopathy) with causative variants located along the entire gene. The remaining patients had a distal or proximal phenotype and a childhood or later (noncongenital) onset. All noncongenital cases had at least one pathogenic variant in one of the final threeTTNexons (362-364). Conclusion Our findings suggest a novel association between the location of nonsense variants and the clinical severity of the disease. |
Databáze: | OpenAIRE |
Externí odkaz: |